Co-authored manuscripts, reviews, and book chapters:

  1. Li BX, Dai X, Xu XR, Adili R, Neves MAD, Lei X, Shen C, Zhu G, Wang Y, Zhou H, Hou Y, Ni T, Pasman Y, Yang Z, Qian F, Zhao Y, Gao Y, Liu J, Teng M, Marshall AH, Cerenzia EG, Li ML, Ni H. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom-derived anti-thrombotic agent targeting human platelet GPIbα. Scientific Reports. 2021 Jun;11(1):11663.
  2. McMillan C, D’Hondt V, Marshall AH, Binhammer P, Lipa J, Snell L. Surgeon-reported needs for improved training in identifying and managing free flap compromise. Journal of Reconstructive Microsurgery. 2017 Jul;33(6):381-388.
  3. Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, Ni H. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Critical Reviews in Clinical Laboratory Sciences. 2016 Dec;53(6):409-30.
  4. Zdravic D, Yougbare I, Vadasz B, Li C, Marshall AH, Chen P, Kjeldsen-Kragh J, Ni H. Fetal and neonatal alloimmune thrombocytopenia. Seminars in Fetal and Neonatal Medicine. 2016 Feb;21(1):19-27.
  5. Hou Y, Carrim N, Wang Y, Gallant RC, Marshall AH, Ni H. Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis. Journal of Biomedical Research. 2015 Oct 30;29(6):437-44.
  6. Yougbare I, Lang S, Yang H, Boyd S, Chen P, Zhao X, Tai W-S, Zdravic D, Vadasz B, Li C, Piran S, Marshall AH, Zhu G, Tiller H, Killie MK, Leong-Poi H, Wen X-Y, Skogen B, Adamson SL, Freedman J, Ni H. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. Journal of Clinical Investigation. 2015;125(4):1545-56.
  7. Wang Y, Reheman A, Spring CM, Kalantari J, Marshall AH, Wolberg AS, Gross PL, Weitz JI, Rand ML, Moser DF, Freedman J, Ni H. Plasma fibronectin supports hemostasis and regulates thrombosis. Journal of Clinical Investigation. 2014;124(10):4281-93.
  8. Marshall AH, Wang Y, Reheman A, Chen P, Zhu G, and Ni H. Chapter 6206: The platelet as a physiological object in the circulation. Pathobiology of Human Disease: A dynamic encyclopedia of disease mechanisms. Elsevier 2014; 3101-3114.
  9. Lei X, Reheman A, Hou Y, Zhou H, Wang Y, Marshall AH, Liang C, Dai X, Li BX, Vanhoorelbeke K, Ni H. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thrombosis and Haemostasis. 2014;111(2):279-89.
  10. Diao L, Marshall AH, Dai X, Bogdanovic E, Abdullahi A, Amini-Nik S, Jeschke MG. Burn plus lipopolysaccharide augments endoplasmic reticulum stress and NLRP3 inflammasome activation and reduces PGC-1α in liver. Shock. 2014;41(2):138-44.
  11. Brooks NC, Marshall AH, Qa’aty N, Hiyama Y, Boehning D, Jeschke MG. XBP-1s is linked to suppressed gluconeogenesis in the Ebb phase of burn injury. Molecular Medicine. 2013;19:72-8.
  12. Marshall AH, Brooks NC, Hiyama Y, Qa’aty N, Al-mousawi A, Finnerty CC, Jeschke MG. Hepatic apoptosis post-burn is mediated by c-Jun N-terminal kinase-2. Shock. 2013;39(2):183-8.
  13. Hiyama Y, Marshall AH, Kraft R, Qa’aty N, Arnó A, Herndon DN, Jeschke MG. Effects of metformin on burn-induced hepatic endoplasmic reticulum stress in male rats. Molecular Medicine. 2013;19:1-6.
  14. Hiyama Y, Marshall AH, Kraft R, Arnó A, Jeschke MG. Fenofibrate does not affect burn-induced hepatic endoplasmic reticulum stress. Journal of Surgical Research. 2013;185(2):733-9.
  15. Kuliszewski MA, Ward MR, Kowalewski JW, Smith AH, Stewart DJ, Kutryk MJB, Leong-Poi H. A direct comparison of endothelial progenitor cell dysfunction in rat metabolic syndrome and diabetes. Atherosclerosis. 2013;226(1):58-66.
  16. Smith AH, Kuliszewski MA, Liao C, Rudenko D, Stewart DJ, Leong-Poi H. Sustained improvement in perfusion and flow reserve after temporally separated delivery of VEGF and Angiopoietin-1 plasmid DNA. Journal of the American College of Cardiology. 2012;59(14):1320-8.
  17. Arno A, Smith AH, Blit PH, Shehab MA, Gauglitz GG, Jeschke MG. Stem cell therapy: a new treatment for burns? Pharmaceuticals. 2011;4(10):1355-1380.
  18. Smith AH, Fujii H, Kuliszewski MA, Leong-Poi H. Contrast ultrasound and targeted microbubbles: Diagnostic and therapeutic applications for angiogenesis. Journal of Cardiovascular and Translational Research. 2011;4(4):404-15.
  19. Smith AH, Kuliszewski MA, Liao C, Rudenko D, Leong-Poi H. Sustained improvement in perfusion and flow reserve after temporally separated ultrasound-mediated multi-gene delivery. ASE Scientific Sessions 2011;SS02c. (Oral presentation, ASE Scientific Sessions June 2011, Finalist, Young Investigator’s Award)
  20. Kuliszewski MA, Fujii H, Liao C, Smith AH, Xie A, Lindner JR, Leong-Poi H. Molecular Imaging of Endothelial Progenitor Cell Engraftment Using Contrast-enhanced Ultrasound and Targeted Microbubbles. Cardiovascular Research. 2009;83(4):653-63.

Acknowledged for my contribution to:

  1. Pang Y, Zhao Y, Wang Y, Wang X, Wang R, Liu N, Li P, Ji M, Ye J, Sun T, Li J, Ma D, Lu F, Ji C. TNFAIP8 promotes AML chen-resistance by activating ERK signaling pathway through interaction with Rac1. Journal of Experimental and Clinical Cancer Research 2020 Aug;39:158.
  2. Zhou W, Zhang L, Chen P, Li S, Cheng Y. Thymine DNA glycosylase-regulated TAZ promotes radio resistance by targeting nonhomologous end joining and tumor progression in esophageal cancer. Cancer Science 2020 Oct;111(10):3613-25.
  3. Sun Y, Li S, Yu W, Chen C, Liu T, Li L, Zhang D, Zhao Z, Gao J, Wang X, Shi D, Liu L. CD148 serves as a prognostic marker of gastric cancer and hinders tumor progression by dephosphorylating EGFR. Journal of Cancer 2020 Feb;11(9):2667-78.
  4. Zhou H, Qin P, Liu Q, Yuan C, Has Y, Zhang H, Wang Z, Ran X, Chu X, Yu W, Wang X, Hou Y, Peng J, Hou M. A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia. American Journal of Hematology 2019 Dec;94(12):1374-1381.
  5. Sheng Z, Li J, Wang Y, Li S, Hou M, Peng J, Feng Q. A CARD9 single-nucleotide polymorphism rs4077515 is associated with reduced susceptibility to and severity of primary immune thrombocytopenia. Annals of Hematology 2019 Nov;98(11):2497-2506.
  6. Zhao Y, Ni X, Xu P, Liu Q, Sun T, Liu X, Ji X, Qiu J, Li J, Want S, Han P, Peng J, Hou M, Li G. Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP). Cytokine 2019 Sep;125:154853. [Epub ahead of print] 
  7. Nie M, Liu Y, Li XX, Min YN, Yang DD, Li Q, Feng Q, Hou Y, Li GS, Sun JZ, Hou M, Shi Y. PD-1/PD-L pathway potentially involved in ITP immunopathogenesis. Thrombosis and Haemostasis 2019 May;119(5):758-765.
  8. Hua M, Li J, Wang C, Shao L, Hou M, Peng J, Feng Q. Aberrant expression of microRNA in CD4+ cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia. Thrombosis Research 2019 May;177:70-78.
  9. Wang L, Xu L, Hao H, Jansen AJG, Liu G, Li H, Liu X, Zhao Y, Peng J, Hou M. First line treatment of adult patients with primary immune thrombocytopenia: a real-world study. Platelets 2019 Feb:1-7.
  10. Li X, Wang SW, Feng Q, Hou Y, Lu N, Ma CH, Gao CJ, Hou M, Peng J. Novel muring model of immune thrombocytopaenia through immunized CD41 knockout mice. Thrombosis and Haemostasis 2019 Mar;119(3):377-383.
  11. Zhao HY, Ma YH, Li DQ, Sun T, Li LZ, Li P, Liu XG, Zhou H, Hou Y, Liu Y, Han PP, Zhao YJ, Jing FM, Peng J, Hou M. Low-dose chidamide restores immune tolerance in ITP in mice and humans. Blood 2019 Feb;133(7):730-742.
  12. Li W, Ji M, Lu F, Pang Y, Dong X, Zhang J, Li P, Ye J, Sang S, Ma D, Ji C. Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia. Cell Death and Disease 2018 Sep; 9(9):855.
  13. Liu H, Jiang W, Chen X, Chang G, Zhao L, Li X, Zhang H. Skeletal muscle-specific Sidt2 knockout in mice induced muscular dystrophy-like phenotype. Metabolism 2018 Aug;85:259-270.
  14. Liu XG, Bai XC, Chen FP, Cheng YF, Dai KS, Fang MY, Feng JM, Gong YP, Guo T, Guo XH, Han Y, Hong LJ, Hu Y, Hua BL, Huang RB, Li Y, Peng J, Shu MM, Sun J, Sun PY, Sun YQ, Wang CS, Wang SJ, Wang XM, Wu CM, Wu WM, Yan ZY, Yang FE, Yang LH, Yang RC, Yang TH, Ye X, Zhang GS, Zhang L, Zheng CC, Zhou H, Zhou M, Zhou RF, Zhou ZP, Zhu HL, Zhu TN, Hou M. Chinese guidelines for treatment of adult primary immune thrombocytopenia. International Journal of Hematology 2018 Jun;107(6):615-623.
  15. Yu Y, Shi Y, Zuo X, Feng Q, Hou Y, Tang W, Lu Y, Yi F, Hou M, Yu Y, Peng J. Progranulin facilitates the increase of platelet count in immune thrombocytopenia. Thrombosis Research. 2018 Apr;164:24-31.
  16. Huang R, Shi Z, Chen L, Zhang Y, Li J, An Y. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice. European Journal of Pharmacology 2017 Nov;814:151-160.
  17. Feng Q, Xu M, Yu YY, Hou Y, Mi X, Sun YX, Ma S, Zuo XY, Shao LL, Hou M, Zhang XH, Peng J. High-dose dexamethasone or all-trans retinoic acid restores the balance of macrophage toward M2 in Immune thrombocytopenia. Journal of Thrombosis and Haemostasis 2017 Jul. 2017 Sep;15(9):1845-1858.
  18. Kong Z, Qin P, Xiao S, Zhou H, Li H, Yang R, Liu X, Luo J, Li Z, Ji G, Cui Z, Bai Y, Wu Y, Shao L, Peng J, Ma J, Hou M. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancyBlood. 2017 Aug 31;130(9):1097-1103.
  19. Li J, Ma S, Shao L, Ma C, Gao C, Zhang XH, Hou M, Peng J. Inflammation-Related Gene Polymorphisms Associated With Primary Immune Thrombocytopenia. Frontiers in Immunology. 2017 Jun;8:744.
  20. Zhu G, Zhang Q, Reddy EC, Carrim N, Chen Y, Xu XR, Xu M, Wang Y, Hou Y, Ma L, Li Y, Rui M, Petruzziello T, Lavalle C, Stratton TW, Lei X, Reheman A, Chen P, Zhu C, Wilkins JA, Hynes RO, Freedman J, Ni H. Integrin PSI domain has endogenous thiol isomerase function and is a novel target for anti-platelet therapy. Blood. 2017 Mar;129(13):1840-1854.
  21. Pan X, Chen Z, Fei G, Pan S, Bao W, Ren S, Guan Y, Zhong C. Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer’s disease. Neuroscience Bulletin. 2016 Dec;32(6):591-596.
  22. Liu Z, Wang M, Zhou S, Ma J, Shi Y, Peng J, Hou M, Guo C. Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia. Journal of Translational Medicine. 2016 Oct 24;14(1):301.
  23. Liu X-G, Liu S, Feng Q, Liu X-N, Li G-S, Sheng Z, Chen P, Liu Y, Wei Y, Dong X-Y, Qin P, Gao C, Ma C, Zhang L, Hou M, Peng J. Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP. Blood 2016 Aug;128:852-861.
  24. Wang Y, Gallant RC, Ni H. Extracellular matrix proteins in the regulation of thrombus formation. Current Opinions in Hematology. 2016 May;23(3):280-7.
  25. Wei Y, Ji XB, Wang YW, Wang JX, Yang EQ, Wang ZC, Sang YQ, Bi ZM, Ren CA, Zhou F, Liu GQ, Peng J, Hou M. High-dose dexamethasone versus prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. Blood. 2016 Jan;127(3):296-302.
  26. Ma L, Simpson E, Li J, Xuan M, Xu M, Baker L, Shi Y, Zhu G, Chen P, Lazarus A, Freedman J, Ni H. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of autoimmune thrombocytopenia. Blood. 2015 Jul;126(2):247-56.
  27. Li J, van der Wal DE, Zhu G, Yougbare I, Ma L, Vadasz B, Grozovsky R, Ruan M, Zhu L, Zeng Q, Leytin V, Freedman J, Hoffmeister KM, Ni H. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune-mediated thrombocytopenia. Nature Communications. 2015 Jul;6:7737.
  28. Ni H. Chapter 3: Adhesion Molecules. Mechanisms in Hematology 4th Edition. Core Health Services Inc. 2014. (in press)
  29. Vadasz B, Chen P, Yougbare I, Zdravic D, Li J, Li C, Carrim N, Ni H. Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia. Genes and Diseases. 2015;2(2):173-185.
  30. Shao L, Wu Y, Zhou H, Qin P, Ni H, Peng J, Hou M. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Platelets. 2015;26(5):495-7.
  31. Ren J, Hou XY, Ma SH, Zhang FK, Zhen JH, Sun L, Sun YX, Hao YL, Cheng YF, Hou M, Xu CG, Zhang MH, Peng J. Elevated expression of CX3C chemokine receptor 1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anaemia. Journal of Internal Medicine. 2014;276(5):512-24.
  32. Reheman A, Xu X, Reddy EC, Ni H. Targeting activated platelets and fibrinolysis: hitting two birds with one stone. Circulation Research. 2014;114(7):1070-3.
  33. Li J, Callum JL, Lin Y, Zhou Y, Zhu G, Ni H. Severe platelet desialyation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage. Haematologica. 2014;99(4):e61-63.
  34. Ren J, Hou XY, Ma SH, Zhang FK, Zhen JH, Sun L, Sun YX, Hao YL, Cheng YF, Hou M, Xu CG, Zhang MH, Peng J. Elevated expression of CX3CR1 mediates recruitment of T cells into bone marrow of patients with acquired aplastic anemia. Journal of Internal Medicine. 2014;276(5):512-24.
  35. Peng J, Ma SH, Liu J, Hou Y, Liu XM, Niu T, Xu RR, Guo CS, Wang XM, Cheng YF, Ni H, Hou M. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicentre cohort study. Journal of Thrombosis and Haemostasis. 2014;12(4):497-504.
  36. Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H. Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia. Thrombosis and Haemostasis. 2013;110(6):1250-8.

Edited manuscripts also published in:

Blood, Scientific Reports, Biochemical and Biophysical Research Communications, Oncotarget, EBioMedicine, Cytokine, and Journal of Human Genetics, Thrombosis and Haemostasis